Target intelligence / Profile preview

Lipid peroxidation of membrane polyunsaturated fatty acids (LPO)

Target
LPO
Molecular classification
Biochemical process, Other
01

Overview

Lipid peroxidation of membrane polyunsaturated fatty acids (PUFAs) is a complex biochemical process involving the oxidative degradation of lipids. It typically proceeds via a free radical chain reaction consisting of initiation, propagation, and termination stages, where reactive oxygen species (ROS) or lipoxygenases abstract hydrogen atoms from the methylene groups of PUFAs (Ayala et al., 2014, Oxid Med Cell Longev). This leads to the formation of lipid hydroperoxides and highly reactive electrophilic aldehydes, such as malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE), which can form adducts with proteins and DNA, causing cellular dysfunction (Gaschler & Stockwell, 2017, Biochem Biophys Res Commun). The accumulation of these lipid peroxides is the defining execution step of ferroptosis, a form of iron-dependent regulated cell death (Stockwell et al., 2017, Cell). Pathologically, excessive lipid peroxidation is implicated in neurodegenerative diseases like Alzheimer's and Parkinson's, as well as atherosclerosis and ischemia-reperfusion injury (Conrad et al., 2018, Nat Chem Biol). Therapeutic strategies targeting this process include the use of radical-trapping antioxidants (RTAs) like Ferrostatin-1, iron chelators to prevent Fenton chemistry, and the activation of the glutathione-GPX4 axis to neutralize lipid hydroperoxides (Stockwell, 2022, Nat Rev Cancer).

Other names
Membrane lipid peroxidationPUFA peroxidationOxidative lipid degradationLipid peroxidation process
02

Mechanism of action

Radical trapping and chain-breaking antioxidant activity to prevent the propagation of lipid peroxyl radicals, iron chelation to inhibit Fenton-mediated initiation, and enzymatic reduction of lipid hydroperoxides (Stockwell et al., 2017, Cell).

03

Biological functions

Cell deathMembrane degradationOxidative stress responseSignal transduction
04

Disease associations

Neurodegenerative diseaseCancerCardiovascular diseaseInflammationIschemia-reperfusion injury
05

Safety considerations

Interference with physiological reactive oxygen species (ROS) signalingPotential pro-oxidant activity under specific conditionsBioavailability and metabolic stability challenges for lipid-soluble inhibitors
06

Interacting drugs

Alpha-tocopherol

5 more in the full profile.

07

Biomarkers

Malondialdehyde (MDA)4-Hydroxynonenal (4-HNE)F2-isoprostanesC11-BODIPY 581/591

Beyond the preview

Go deeper on Lipid peroxidation of membrane polyunsaturated fatty acids (LPO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid peroxidation of membrane polyunsaturated fatty acids (LPO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call